|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 October 2002, Vol. 100, No. 7, pp. 2463-2471
HEMATOPOIESIS
The antiapoptosis protein survivin is associated with
cell cycle entry of normal cord blood CD34+ cells and
modulates cell cycle and proliferation of mouse hematopoietic
progenitor cells
Seiji Fukuda,
Richard G. Foster,
Scott B. Porter, and
Louis M. Pelus
From the Department of Microbiology and Immunology and
the Walther Oncology Center, Indiana University School of Medicine; and
the Walther Cancer Institute, Indianapolis, IN.
The inhibitor of the apoptosis protein (IAP) survivin is
expressed in proliferating cells such as fetal tissues and cancers. We
previously reported that survivin is expressed and growth factor regulated in normal adult CD34+ cells. Herein, we examined
survivin expression in CD34+ cells before and after cell
cycle entry and demonstrate a role for survivin in cell cycle
regulation and proliferation. Analysis of known human IAPs revealed
that only survivin is cytokine regulated in CD34+ cells.
Survivin expression is coincident with cell cycle progression. Up-regulation of survivin by thrombopoietin (Tpo), Flt3 ligand (FL),
and stem cell factor (SCF) occurred in
underphosphorylated-retinoblastoma protein (Rb)positive,
Ki-67negative, and cyclin Dnegative
CD34+ cells. Quantitative real-time reverse
transcription-polymerase chain reaction (RT-PCR) and
multivariate flow cytometry demonstrated that Tpo, SCF, and FL increase
survivin mRNA and protein in quiescent G0 CD34+
cells without increasing Ki-67 expression, indicating that
cytokine-stimulated up-regulation of survivin in CD34+
cells occurs during G0, before cells enter G1.
Selective inhibition of the PI3-kinase/AKT and
mitogen-activated protein kinase (MAPKp42/44) pathways
blocked survivin up-regulation by growth factors before arresting cell
cycle. Retrovirus transduction of survivin-internal ribosome entry
site-enhanced green fluorescent protein (survivin-IRES-EGFP) in primary mouse marrow cells increased granulocyte
macrophage-colony-forming units (CFU-GM) by 1.7- to
6.2-fold and the proportion of CFU-GM in S phase, compared to vector
control. An antisense survivin construct decreased total and S-phase
CFU-GM. These studies provide further evidence that survivin
up-regulation by growth factors is not a consequence of cell
cycle progression and strongly suggest that survivin is an
important early event for cell cycle entry by CD34+ cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Fukuda, P. Singh, A. Moh, M. Abe, E. M. Conway, H. S. Boswell, S. Yamaguchi, X.-Y. Fu, and L. M. Pelus
Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3
Blood,
July 9, 2009;
114(2):
394 - 403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hoggatt, P. Singh, J. Sampath, and L. M. Pelus
Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation
Blood,
May 28, 2009;
113(22):
5444 - 5455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Yue, A. Carvalho, Z. Xu, X. Yuan, S. Cardinale, S. Ribeiro, F. Lai, H. Ogawa, E. Gudmundsdottir, R. Gassmann, et al.
Deconstructing Survivin: comprehensive genetic analysis of Survivin function by conditional knockout in a vertebrate cell line
J. Cell Biol.,
October 20, 2008;
183(2):
279 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fukuda, H. Bian, A. G. King, and L. M. Pelus
The chemokine GRO{beta} mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment
Blood,
August 1, 2007;
110(3):
860 - 869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, T. S. Park, and J. M. Gidday
Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation
Am J Physiol Heart Circ Physiol,
June 1, 2007;
292(6):
H2573 - H2581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-F. Wang, M. Birringer, L.-F. Dong, P. Veprek, P. Low, E. Swettenham, M. Stantic, L.-H. Yuan, R. Zobalova, K. Wu, et al.
A Peptide Conjugate of Vitamin E Succinate Targets Breast Cancer Cells with High ErbB2 Expression
Cancer Res.,
April 1, 2007;
67(7):
3337 - 3344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Sloand, L. Pfannes, G. Chen, S. Shah, E. E. Solomou, J. Barrett, and N. S. Young
CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins
Blood,
March 15, 2007;
109(6):
2399 - 2405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Gude, J. Muraski, M. Rubio, J. Kajstura, E. Schaefer, P. Anversa, and M. A. Sussman
Akt Promotes Increased Cardiomyocyte Cycling and Expansion of the Cardiac Progenitor Cell Population
Circ. Res.,
August 18, 2006;
99(4):
381 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Li and M. G. Brattain
Role of the SurvivinGene in Pathophysiology
Am. J. Pathol.,
July 1, 2006;
169(1):
1 - 11.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fukuda and L. M. Pelus
Survivin, a cancer target with an emerging role in normal adult tissues
Mol. Cancer Ther.,
May 1, 2006;
5(5):
1087 - 1098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hirata, S. Maeda, T. Ohmae, W. Shibata, A. Yanai, K. Ogura, H. Yoshida, T. Kawabe, and M. Omata
Helicobacter pylori Induces I{kappa}B Kinase {alpha} Nuclear Translocation and Chemokine Production in Gastric Epithelial Cells
Infect. Immun.,
March 1, 2006;
74(3):
1452 - 1461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Mao, M. C. Fishbein, B. Adams, M. D. Roth, L. Goodglick, L. Hong, M. Burdick, E. R. M. Strieter, C. Holmes, D. P. Tashkin, et al.
Celecoxib Decreases Ki-67 Proliferative Index in Active Smokers
Clin. Cancer Res.,
January 1, 2006;
12(1):
314 - 320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kawamura, J. Fukuda, Y. Shimizu, H. Kodama, and T. Tanaka
Survivin Contributes to the Anti-Apoptotic Activities of Transforming Growth Factor alpha in Mouse Blastocysts Through Phosphatidylinositol 3'-Kinase Pathway
Biol Reprod,
December 1, 2005;
73(6):
1094 - 1101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kozak
A second look at cellular mRNA sequences said to function as internal ribosome entry sites
Nucleic Acids Res.,
November 28, 2005;
33(20):
6593 - 6602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Wang, J. Sampath, S. Fukuda, and L. M. Pelus
Disruption of the Inhibitor of Apoptosis Protein Survivin Sensitizes Bcr-abl-Positive Cells to STI571-Induced Apoptosis
Cancer Res.,
September 15, 2005;
65(18):
8224 - 8232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Baratelli, K. Krysan, N. Heuze-Vourc'h, L. Zhu, B. Escuadro, S. Sharma, K. Reckamp, M. Dohadwala, and S. M. Dubinett
PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells
J. Leukoc. Biol.,
August 1, 2005;
78(2):
555 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fukuda, H. E. Broxmeyer, and L. M. Pelus
Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1{alpha}(CXCL12)/CXCR4 axis
Blood,
April 15, 2005;
105(8):
3117 - 3126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Johnson and E. W. Howerth
Survivin: A Bifunctional Inhibitor of Apoptosis Protein
Vet. Pathol.,
November 1, 2004;
41(6):
599 - 607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jiang, H. I. Saavedra, M. P. Holloway, G. Leone, and R. A. Altura
Aberrant Regulation of Survivin by the RB/E2F Family of Proteins
J. Biol. Chem.,
September 24, 2004;
279(39):
40511 - 40520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, R.-H. Wang, W. Li, X. Xu, M. C. Hollander, A. J. Fornace Jr., and C.-X. Deng
Genetic Interactions between Brca1 and Gadd45a in Centrosome Duplication, Genetic Stability, and Neural Tube Closure
J. Biol. Chem.,
July 9, 2004;
279(28):
29606 - 29614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Altznauer, S. Martinelli, S. Yousefi, C. Thurig, I. Schmid, E. M. Conway, M. H. Schoni, P. Vogt, C. Mueller, M. F. Fey, et al.
Inflammation-associated Cell Cycle-independent Block of Apoptosis by Survivin in Terminally Differentiated Neutrophils
J. Exp. Med.,
May 17, 2004;
199(10):
1343 - 1354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Ling, R. J. Bernacki, M. G. Brattain, and F. Li
Induction of Survivin Expression by Taxol (Paclitaxel) Is an Early Event, Which Is Independent of Taxol-mediated G2/M Arrest
J. Biol. Chem.,
April 9, 2004;
279(15):
15196 - 15203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fukuda, C. R. Mantel, and L. M. Pelus
Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways
Blood,
January 1, 2004;
103(1):
120 - 127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Herodin, P. Bourin, J.-F. Mayol, J.-J. Lataillade, and M. Drouet
Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma -irradiation promotes survival
Blood,
April 1, 2003;
101(7):
2609 - 2616.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|